Shivalik Rasayan Limited — Board Meeting, 12-08-2025: Outcome of Board Meeting

Shivalik Rasayan's board has approved its Q1 FY25 consolidated financial results. Revenue climbed to ₹89.91 Cr, up from ₹75.27 Cr year-on-year, though net profit saw a dip to ₹2.82 Cr compared to ₹3.87 Cr last year. The board also approved a ₹0.50 per share final dividend (10%) for FY24-25, pending shareholder approval at the 47th AGM on September 27, 2025. A key strategic move includes the incorporation of a wholly-owned subsidiary to venture into Pesticides Formulations, a forward integration step. Additionally, Mr. Ashwani Kumar Sharma's redesignation as a Non-Executive, Non-Independent Director was approved, subject to shareholder consent.